SpotOnTrade Wednesday, 12/11/19 08:27:09 PM Re: Value_Investor post# 5553 Post # of 5608 $BNGO Dr. from the MD Anderson Cancer Center demonstrated 100% concordance between data generated with Saphyr and structural variant data generated with “gold standard” cytogenetic methods in five bone marrow specimens with hematological malignancies. All previously identified cytogenetic abnormalities detected by karyotyping, FISH or microarray analysis were detected by Saphyr. In addition, several novel structural and copy number changes were detected. http://www.globenewswire.com/news-release/2019/10/24/1934941/0/en/Takeaways-from-ASHG-2019-in-Houston-Users-of-Bionano-s-Saphyr-System-Presented-Validation-Results-for-FSHD-Repeat-Expansion-Disorders-and-Digital-Cytogenetics-Among-a-Growing-List-.html https://bionanogenomics.com/wp-content/uploads/2019/09/Bionano-Genomics-GenomeWeb-Dr-Jim-Broach-Webinar-White-Paper_0919.pdf Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.